Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > News > CombiMatrix Group to Receive $10 Million from Acacia Research

December 8th, 2006

CombiMatrix Group to Receive $10 Million from Acacia Research

Acacia Research Corporation (Nasdaq:CBMX) (Nasdaq:ACTG) announced today that it has obtained commitments to purchase approximately $10 million of its Acacia Research-CombiMatrix common stock and warrants in a registered direct offering. Under the terms of the transaction, Acacia will sell approximately 9.8 million units for $1.02 per unit to a select group of investors. Each unit will consist of one share of Acacia Research-CombiMatrix common stock and a five year warrant for the purchase of 1.2 shares of common stock at an exercise price of $0.87 per share. Oppenheimer & Co. Inc. acted as exclusive placement agent for the transaction.


Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Nanometrics Announces Upcoming Investor Events November 18th, 2015

Harris & Harris Group Portfolio Company, D-Wave Systems, Announces Multi-Year Agreement With Lockheed Martin November 16th, 2015

Arrowhead Late-Breaking Clinical Data Shows that ARC-520 Can Produce Deep and Durable Reductions of Hepatitis B Viral Antigens and DNA November 16th, 2015

Harris & Harris Group Portfolio Company, D-Wave Systems, Announces the Sale of Its Latest Quantum Computer to Los Alamos National Laboratory November 11th, 2015


Scientists design a QKD-based quantum private query with no failure November 25th, 2015

MIT mathematicians identify limits to heat flow at the nanoscale: New formula identifies limits to nanoscale heat transfer, may help optimize devices that convert heat to electricity November 25th, 2015

Physicists explain the unusual behavior of strongly disordered superconductors: Using a theory they developed previously, the scientists have linked superconducting carrier density with the quantum properties of a substance November 25th, 2015

Scientists 'see' detailed make-up of deadly toxin for the first time: Exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia November 25th, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic